Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)
NCT01366898
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Acute Lymphoblastic Leukemia
Interventions
DRUG:
Dexamethasona, Idarubicine, ARA-C, Methotrexate
Sponsor
PETHEMA Foundation